TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells (Q35668744)

9 August 2017

1 reference

title

TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells (English)

1 reference

9 August 2017

0 references

0 references

0 references

Sharon M Wahl

1

1 reference

9 August 2017

Jennifer Swisher

series ordinal

2

1 reference

9 August 2017

Nancy McCartney-Francis

series ordinal

3

1 reference

9 August 2017

Wanjun Chen

series ordinal

4

1 reference

9 August 2017

13 February 2004

1 reference

Journal of Leukocyte Biology

9 August 2017

1 reference

9 August 2017

76

1 reference

9 August 2017

1

1 reference

9 August 2017

15-24

1 reference

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

9 August 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: a balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: receptors, signaling pathways and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Making sense of latent TGFbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: from latent to active

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta signaling from receptors to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Smad6 inhibits signalling by the TGF-beta superfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: 20 years and counting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor-beta in disease: the dark side of tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Oral tolerance, an active immunologic process mediated by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: how tolerant can it be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Acquisition of lymphokine-producing phenotype by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

An overview of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Immune regulation by regulatory T cells: implications for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Suppressor T cells--they're back and critical for regulation of autoimmunity!

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Immunology. Regulating the regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

B cells and professional APCs recruit regulatory T cells via CCL4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Special attractions for suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Foxp3 and natural regulatory T cells: key to a cell lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Infiltration of neutrophils following injection of apoptotic cells into the peritoneal cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta influences the life and death decisions of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Requirement for transforming growth factor beta1 in controlling T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

TGF-beta in infections and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Arginases in parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Cytokine regulation of schistosome-induced granuloma and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta in infectious disease: always there for the host and the pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Transforming growth factor beta production is inversely correlated with severity of murine malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

Immunosuppressive effects of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1103539

21 January 2018

Identifiers

DOI

10.1189/JLB.1103539

1 reference

9 August 2017

1 reference